2024 Policy Topical Treatment 
Veriheal
DECEMBER 15, 2023
Colorado recently passed legislation allowing for “healing centers” utilizing shrooms to start opening as soon as 2024, and Oregon is trending in a similar direction. There is hope for the future, but rescheduling MDMA and subjecting it to rigorous testing and policy considerations are still necessary steps.
Veriheal
MAY 19, 2023
In the meantime, employers will be tasked with doing a thorough review of their current drug testing policies. Even so, the NI says the self-study, along with various other reports, is enough to conclude that this topic deserves further research. The bill goes into effect on Jan.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 4, 2021
The Oregon Psilocybin Advisory Board (Advisory Board) held a meeting on October 27 to begin fine tuning recommendations for the first regulated psilocybin treatment model in the United States. This blog post will discuss the rulemaking timeline and provide updates regarding policy recommendations from the five subcommittees.
Cannabis Law Report
AUGUST 18, 2021
The Hall Act restricts legal usage to that of cannabis products (not hemp) that can be ingested – for example, by tablet or non-sugarcoated gummy – topical products, suppository, transdermal patch, or by nebulizer. The Hall Act expressly does not allow for the use of cannabis products that are smoked or vaped, baked goods, or candies.
The Blunt Truth
OCTOBER 24, 2019
The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. Tourette syndrome and intractable neuropathic pain are now eligible for treatment with medical cannabis.
Cannabis Law Report
AUGUST 4, 2021
from the second half of 2021 onwards as the Group fully repaid in May and June 2021 its 2022 and 2023 Eurobonds and successfully purchased a significant portion of its 2024 and 2026 Eurobonds which were bearing much higher interest rates. Second investment grade credit rating from Fitch Ratings after the one secured with Moody’s last year.
Veriheal
SEPTEMBER 22, 2021
We’re encouraged that SB711 has been advanced by the Judiciary Committee,” said DeVaughn Ward , who serves as senior legislative counsel for the Marijuana Policy Project. The final stage would see the governor put his signature on North Carolina’s medical cannabis bill.
Expert insights. Personalized for you.
104 
Let's personalize your content